As China embraces AI, only 24% of US pharma execs bet on it for drug-making
SCMP Tech (AI)en
SCMP Tech (AI)
AI Global WirePharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey ...
This is a short summary published by AI Global Wire. The full article is owned and hosted by SCMP Tech (AI) — open it there to read it in full.
Read the full story at SCMP Tech (AI)- Forskning
Related AI news
- Anthropic researcher says AI has more than 10% chance of 'killing all humans' after colleague quitsCNBC Technology · September 9, 2026
- SCAFFOLD: Self-Improving Web Agents via Recursive Parametric Skill AbstractionarXiv cs.AI · September 9, 2026
- The Failure Happens Before the Drift: The Social Dynamics of Values in LLM Agent SocietiesarXiv cs.AI · September 9, 2026
- Planning and Scheduling Business Processes under Control-Flow UncertaintyarXiv cs.AI · September 9, 2026
- Agents Trust Tools Too Much: Measuring Reliance on Unreliable ToolsarXiv cs.AI · September 9, 2026
- Distilling Vision-Language Models for On-Device Fire UnderstandingarXiv cs.AI · September 9, 2026